Developers add second building to
Broadway Triangle resi project

Project at former Pfizer property will be two buildings instead of one
By Eddie Small | May 30, 2017 03:50PM

Developers Juda Klein and Abraham Brach have revised their plans for Brooklyn’s Broadway Triangle, opting for two separate residential buildings on the site instead of one 41-unit property.

Klein, who heads Parkview Management, bought the last remaining lot of Pfizer’s Broadway Triangle site with a group of investors led by Brach in January for $27.5 million. Parkview then filed plans in March to build a roughly 100,000-square-foot, seven-story building with 41 residential units on the former site of Pfizer’s headquarters at 58 Gerry Street.

However, the development team now plans to construct two buildings on the site instead of one, essentially splitting their original plans in half, according to Ben Frances of Parkview Management.

Klein filed plans with the city for one of those buildings on Tuesday, a new permit application shows. The mixed-use property would include 3,632 square feet of commercial space and 18 residential units across 37,392 square feet of residential space. The building would span 41,024 square feet in total, and Parkview plans to break ground on it soon.

Although Frances had previously described the development to The Real Deal as “upscale religious housing” for the Orthodox Jewish community, in an interview on Tuesday, he stressed that the project would not just be for members of one group.

“I don’t want to leave anyone out. It’s meant for whoever lives in the area, really,” Frances said. “I don’t want to specify Jewish housing or anything like that.”